Novartis wants to appeal a ruling in its dispute with generic drug maker Pharmacor over patents for its multiple sclerosis drug Gilenya that tossed three of its four experts out of an upcoming so-called hot tub.
A judge has questioned GMEās pursuit of additional damages in its intellectual property lawsuit against Japanās Uniden that alleges the upcoming launch by the wireless communication giant of two new CB radio products amounts to infringement of its design patent.Ā
WA Attorney-General John Quigley wants a second go at his trial testimony in a defamation case brought by mining magnate Clive Palmer, admitting he made “mistakes” while giving evidence in the witness box.
Epic Games has argued in favour of steaming ahead with a trial in its competition case against Apple while its parallel case against Google remains in the embryonic stage, but the tech giants say Google’s litigation should catch up in the hopes that the court can hear a joint trial or hold contemporaneous hearings.
A judge has questioned whether the lead applicant in a class action over sleep apnea machines with alleged safety defects was āappropriately resourcedā to run the case against health tech giant Philips.
A judge has slammed Novartis for putting forward four “overlapping” experts in a dispute with Pharmacor over patents for its MS drug Gilenya and thrown three of those experts out of an upcoming joint conferral, known as a “hot tub”.
Japan’s Uniden has been hit with an intellectual property lawsuit by Australia’s only CB radio manufacturer, which alleges the upcoming launch by the wireless communications giant of two new products amounts to infringement of its design patent.
US bank Wells Fargo and Florida-based aviation leasing company Willis Lease Finance will have to pay $500,000 for the relocation of leased aircraft engines to Virgin after losing a High Court bid to have the airline foot the bill.
Lloyd’s has scored a win in a COVID-19 business interruption case, with a judge ruling the insurer can rely on a conformity clause in its insurance contract with a Snap Fitness franchisee to deny coverage.
The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck’s patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.